FDA Approvals

Date Posted
Article Title
9/18/2015
Vraylar Approved for Schizophrenia, Bipolar Disorder

Label warns against use by certain elderly

9/2/2015
Anti-Nausea Drug Approved

For adults undergoing chemotherapy

8/28/2015
FDA Approves Repatha for High Cholesterol

A leading cause of heart disease

8/24/2015
Promacta Approval Expanded to Kids With Rare Blood Disorder

Immune thrombocytopenic purpura involves low blood platelet counts

8/19/2015
Female Libido Pill Approved

Addyi to treat low sexual desire among premenopausal women

7/29/2015
Balloon Device Approved to Treat Obesity

Inflated in stomach, it may create sense of fullness

7/27/2015
Praluent Approved to Treat High Cholesterol

For people at risk of heart attack or stroke

7/24/2015
Technivie Approved for Hepatitis C

For people with a genetic subtype of the liver infection

7/24/2015
7/24/2015
Test to Differentiate HIV Viruses Approved

Among people two years and older

7/16/2015
Novel Leg Prosthesis Approved

For people who can't use conventional device

7/13/2015
Iressa Approved for Specific Late-Stage Lung Cancer

New companion diagnostic can identify candidates

7/13/2015
Rexulti Approved for Schizophrenia, Depression

But shouldn't be prescribed to some older people

7/7/2015
Entresto Approved for Heart Failure

When heart can't pump enough blood

7/2/2015
Orkambi Approved for Cystic Fibrosis

When disease caused by mutated gene from each parent

6/22/2015
Anti-Clotting Drug Approved For Angioplasty

Kengreal prevents blood platelets from accumulating

6/17/2015
Improved Artificial Heart Valve Approved

Changes designed to minimize leaks

6/15/2015
Brain Stimulation Device Approved for Parkinson's and Essential Tremor

For use after medication alone proves inadequate

5/29/2015
Rapamune Approved for Rare Lung Disease

LAM affects mostly women of child-bearing age

5/28/2015
Two Drugs Approved for Irritable Bowel

Syndrome affects up to 15 percent of U.S. adults